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rationale for target cancer therapies based on inhibitors of 
DDR 
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Colorectal cancer (CRC) is the third most common type of 
cancer among men and the second among women in the 
European region. CRC is the second most common cause of 
cancer related death in Europe. Several trials have shown a 
mortality reduction of screening by either faecal occult blood 
test or flexible sigmoidoscopy. Next to mortality reduction, 
there also is a reduction of the CRC incidence by CRC 
screening. Furthermore, different CRC screening modalities 
have been proven to be cost-effective and maybe even cost-
saving. Most countries of the European Union do have a type 
of CRC screening, but still many countries do have 
opportunistic programs without an explicit policy, defined 
target population and without a dedicated organisation 
responsible for the roll out of the program. Preferable, CRC 
screening should be a population based program, using an up 
to date IT system/ data warehouse and with close monitoring 
and evaluation of the whole program and the outcome 
measures. Quality assurance is of utmost importance and can 
only be established in an organised program. Part of the 
results of the Netherlands CRC screening program will be 
presented as example. 
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Purpose: The delineation of clinical target volume is a 
critical step in radiation therapy procedure. Several 
contouring guidelines suggest different subvolumes and 
anatomical limits in rectal cancer, supporting a variability in 
delineation that largely depends on inter-operator 
discordance in delineation. An international agreement 
among expert radiation oncologists might significantly reduce 
this variability, converging on a consensus rectal cancer 
contouring guideline through Falcon, the educational web-
based multifunctional platform for delineation endorsed by 
ESTRO.  
 
Material and Method: Seven skilled radiation oncologists, 
delegated from ESTRO, ASTRO, TROG and EORTC, defined the 
steps to produce consensus rectal cancer guidelines on 
elective nodal levels delineation. Six rectal cancer cases with 
different clinical stage were selected and the related CT 
scans were shared and uploaded on Falcon platform. The 
experts firstly delineated online the selected CT scan slices 
following each his personal guidelines. The first delineation 
outcome was then discussed in a face-to-face meeting with 
the contribution of surgeons and radiologist and a table of 
boundaries was compiled. All the experts had then to 
delineate online the same CT scan slices, considering the new 
table of boundaries. In a peer review meeting the final 
outcome was obtained and the publication plan defined.  
 
Results: Falcon allowed a comparison of the experts’ 
delineations, identifying critical nodal boundaries as areas of 
disagreement. The ontology of structure sets was defined and 
a new table of boundaries was generated. The major 
modifications to the previously published guidelines were 
about lateral lymph nodes (LLN) and ischiorectal fossa (IRF). 
One of the discussed issues was the level of the cranial and 
anterior border of LLN according to clinical rectal cancer 
stage. The delineation of the entire IRF was recommended 
only when there was an infiltration of the external anal 
sphincter or the IRF and new limits were defined (Table). 
 
 
Conclusion: The definition of consensus guidelines for rectal 
cancer delineation endorsed by skilled radiation oncologists 
may support in reducing contouring variability. The structure 
sets of the six cases used will be available online as 
consultation atlases on the Falcon platform for individual test 
and a paper describing the agreed guidelines will be soon 
published. 
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Historically, the standard treatment modality used for the 
vast majority of small renal masses (< 4 cm) was radical 
nephrectomy (RN). Partial nephrectomy (PN) was conceived 
to preserve renal parenchyma and function. It was pioneered 
in patients who would require renal replacement after RN 
(imperative indications). Based on the “belief” that PN is 
“better” than RN, utilization of PN has increased worldwide 
in the last few years. This has been supported by extensive 
literature of retrospective studies demonstrating renal 
functional outcomes and “overall survival” benefits of PN 
over RN. For T1 renal cancer (up to 7 cm lesion according to 
current TNM), > 95% 5 years disease specific survival rates 
have been reported. The probability of a positive surgical 
margin (PSM) on the resection bed has been shown to be 
below 5%. The impact of a PSM on disease recurrence remains 
controversial with some series suggesting no additional risk 
compared to a negative margin. A tumour resection 
technique conducted at the edge of the tumour (enucleation) 
has been advocated as a mean to preserve more renal 
parenchyma and oncologically “non-inferior” to the standard 
“enucleoresection” technique where a margin of up to 1 cm 
of healthy parenchyma is left on the resected mass. Besides, 
a significant reduction in the risk of developing chronic 
kidney disease (CKD) has been reported with PN as compared 
